SE8107634L - Nya tri-, tetra- och pentapeptider, forfaranden for framstellning av desamma och lekemedel innehallande desamma - Google Patents

Nya tri-, tetra- och pentapeptider, forfaranden for framstellning av desamma och lekemedel innehallande desamma

Info

Publication number
SE8107634L
SE8107634L SE8107634A SE8107634A SE8107634L SE 8107634 L SE8107634 L SE 8107634L SE 8107634 A SE8107634 A SE 8107634A SE 8107634 A SE8107634 A SE 8107634A SE 8107634 L SE8107634 L SE 8107634L
Authority
SE
Sweden
Prior art keywords
tetra
alanyl
pentapeptides
procedures
production
Prior art date
Application number
SE8107634A
Other languages
Unknown language ( )
English (en)
Other versions
SE454699B (sv
Inventor
J Bouchaudon
G Dutruc-Rosset
D Farge
C James
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of SE8107634L publication Critical patent/SE8107634L/sv
Publication of SE454699B publication Critical patent/SE454699B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE8107634A 1980-12-19 1981-12-18 Peptider och lekemedel innehallande desamma SE454699B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8027020A FR2496654A1 (fr) 1980-12-19 1980-12-19 Nouveaux tri-, tetra- et pentapeptides, leur preparation et les medicaments qui les contiennent

Publications (2)

Publication Number Publication Date
SE8107634L true SE8107634L (sv) 1982-06-20
SE454699B SE454699B (sv) 1988-05-24

Family

ID=9249292

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8107634A SE454699B (sv) 1980-12-19 1981-12-18 Peptider och lekemedel innehallande desamma

Country Status (17)

Country Link
US (1) US4401658A (sv)
JP (1) JPS57154151A (sv)
AU (1) AU555294B2 (sv)
BE (1) BE891539A (sv)
CA (1) CA1250398A (sv)
CH (1) CH653039A5 (sv)
DE (1) DE3150295A1 (sv)
DK (1) DK154436C (sv)
FR (1) FR2496654A1 (sv)
GB (1) GB2089816B (sv)
IE (1) IE52113B1 (sv)
IT (1) IT1142148B (sv)
LU (1) LU83843A1 (sv)
NL (1) NL8105587A (sv)
NZ (1) NZ199310A (sv)
SE (1) SE454699B (sv)
ZA (1) ZA818737B (sv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019383A (en) * 1981-01-09 1991-05-28 New York Blood Center, Inc. Fatty acid carriers for synthetic peptides
US6024964A (en) * 1985-06-24 2000-02-15 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
US6074650A (en) * 1985-06-24 2000-06-13 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
WO1988001612A1 (en) * 1986-08-27 1988-03-10 Pfizer Inc. Processes and intermediates for n-(s-3-alkyl-heptanoyl)-d-gamma-glutamyl-glycyl-d-alanine
FI890886L (fi) * 1986-08-27 1989-02-24 Pfizer Kristallin n-(s-3-metylheptanoyl) -d-gamma-glutamyl-glycyl-d-alanin och foerfaranden foer dess framstaellning samt mellanprodukter.
US4874608A (en) * 1987-04-27 1989-10-17 Imreg, Inc. Therapeutic method for treating malignancies
DE68924265T2 (de) * 1989-01-18 1996-02-15 Medisa Shinyaku Inc Verwendung von einem reagens zum nachweis eines mit einem säurebeständigen bakterienantigen übereinstimmenden antikörpers.
US5721109A (en) * 1989-01-18 1998-02-24 Sawai Pharmaceutical Co., Ltd. Method for diagnosing infection caused by acid-fast bacterium
US5134225A (en) * 1989-02-21 1992-07-28 Pfizer Inc. Processes and intermediates for N-(S-3-alkyl-heptanoyl)-D-gamma-glutamyl-D-alanine
US5248820A (en) * 1989-02-21 1993-09-28 Pfizer Inc. Crystalline N-(S-3-methylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine, and processes and intermediates therefor
US5245079A (en) * 1989-02-21 1993-09-14 Pfizer Inc. Processes and intermediates for N-(S-3-alkyl-heptanoyl)-D-gamma-glutamyl-glycyl-D-alanine
US5136020A (en) * 1989-02-21 1992-08-04 Pfizer Inc. Crystalline n-(s-3-methylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine, and processes and intermediates therefor
US5185464A (en) * 1989-02-21 1993-02-09 Pfizer Inc. Crystalline N-(S-3-methylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine, and processes and intermediates therefor
DE9110182U1 (de) * 1991-08-17 1992-12-17 Wilhelm Koch GmbH, 4830 Gütersloh Einbauleuchte
AUPO161196A0 (en) * 1996-08-13 1996-09-05 Commonwealth Scientific And Industrial Research Organisation Novel compounds
KR101219880B1 (ko) * 2010-10-08 2013-01-08 한국생산기술연구원 나노 버블을 이용한 두부제조방법
WO2012142659A1 (en) * 2011-04-19 2012-10-26 Baker Idi Heart And Diabetes Institute Holdings Limited Site-selective modification of proteins
EP2975046A1 (en) 2014-07-16 2016-01-20 The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth Novel compounds
CN110092735B (zh) * 2018-01-31 2021-05-11 尚科生物医药(上海)有限公司 一种l-丙氨酸衍生物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2033906B (en) * 1978-10-19 1982-12-01 Anvar Water-soluble compounds derived from extracts of streptomyces stimulosus process for their production and compositions containing them
DE2963446D1 (en) * 1978-11-14 1982-09-16 Fujisawa Pharmaceutical Co New lactyl tetrapeptide, processes for preparation thereof and pharmaceutical compositions containing it
US4311640A (en) * 1978-11-14 1982-01-19 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
FR2460290A1 (fr) * 1979-06-29 1981-01-23 Rhone Poulenc Ind Nouveaux tetra- ou pentapeptides, leur preparation et les medicaments qui les contiennent
FR2460289A1 (fr) * 1979-06-29 1981-01-23 Rhone Poulenc Ind Nouveaux tripeptides, leur preparation et les medicaments qui les contiennent

Also Published As

Publication number Publication date
AU7859081A (en) 1982-06-24
LU83843A1 (fr) 1982-07-07
NZ199310A (en) 1985-10-11
FR2496654B1 (sv) 1983-12-16
SE454699B (sv) 1988-05-24
DK154436C (da) 1989-04-17
DK563181A (da) 1982-06-20
CA1250398A (fr) 1989-02-21
IE52113B1 (en) 1987-06-24
JPH0337560B2 (sv) 1991-06-05
JPS57154151A (en) 1982-09-22
IT8125703A0 (it) 1981-12-18
US4401658A (en) 1983-08-30
AU555294B2 (en) 1986-09-18
BE891539A (fr) 1982-06-18
IE812974L (en) 1982-06-19
IT1142148B (it) 1986-10-08
GB2089816A (en) 1982-06-30
DK154436B (da) 1988-11-14
CH653039A5 (fr) 1985-12-13
ZA818737B (en) 1982-11-24
NL8105587A (nl) 1982-07-16
DE3150295A1 (de) 1982-07-29
GB2089816B (en) 1984-07-18
FR2496654A1 (fr) 1982-06-25

Similar Documents

Publication Publication Date Title
IE812974L (en) Tri-,tetra- and penta peptides
SE8004792L (sv) Nya tetra- eller pentapeptider, forfaranden for framstellning av desamma och farmaceutiska kompositioner innehallande desamma
FI881134A0 (fi) Difosfonsyraderivat och laekemedel innehaollande detsamma.
SE9203825L (sv) Dubbelt verkande inhibitorer foer no-syntas och cyklooxygenas, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma
FI864614A0 (fi) Nya difosfonsyraderivat, foerfaranden foer framstaellning av dessa samt laekemedel innehaollande dessa foereningar.
NO974734D0 (no) Arylglycinamidderivater, fremgangsmåte for fremstilling av disse forbindelsene og farmasöytiske blandinger inneholdende slike forbindelser
NO913773L (no) Tripeptid antitrombotiske midler.
BG101402A (en) Apoliprotein-b synthesis inhibitors
FR2719043B1 (fr) Nouveaux composés bicycliques-aromatiques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
ATE191908T1 (de) Neue verbindungen
IL111581A (en) Cyclic amino acid derivatives pharmaceutical compositions containing them and process for their preparation
IL69056A0 (en) Ketenethioacetal derivatives,their preparation and pharmaceutical compositions containing them
IL105834A0 (en) Sulfur containing phosphonate compounds and pharmaceutical compositions containing them
FR2707089B1 (fr) Nouveaux dérivés d'acide phosphonique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
ATE116647T1 (de) Thiophenderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DE3162053D1 (en) N-acyl peptide compounds, processes for the preparation thereof and pharmaceutical compositions containing them
ATE69611T1 (de) Piperazinylalkylpiperazindion-derivate, ihre verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen.
FR2713644B1 (fr) Nouveaux analogues de l'éburnane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
DE69100897D1 (de) N-phenyl-n-alkoxycarbonylalkyl-glycinamide, ihre herstellung und sie enthaltende medikamente.
EP0088986A3 (en) Bicyclic phenol ethers, process for their preparation and medicines containing these compounds
ATE46347T1 (de) Immunostimulierende peptide.
ATE120736T1 (de) Benzylselenobenzamide von aminopyridinen und picolylaminen.
PT88976A (pt) Processo para a preparacao de derivados de tienoimidazol substituidos e de composicoes farmaceuticas que os contem
SE9902147L (sv) Nya föreningar och farmaceutiska kompositioner innehållande desamma
MX9705270A (es) Nuevos inhibidores de farnesiltransferasa, su preparacion y las composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8107634-1

Effective date: 19930709

Format of ref document f/p: F